Reducing TDP-43 aggregation does not prevent its cytotoxicity

Acta Neuropathologica Communications

Volumn 2, Issue 1, 2014, Pages

  Liu, Rui ^a   Yang, Guang ^a   Nonaka, Takashi ^b   Arai, Tetsuaki ^c   Jia, William ^a   Cynader, Max S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Aggregation; Cell death; Peptides; TDP 43

Indexed keywords

ARSENIC TRIOXIDE; ARSENOUS ACID DERIVATIVE; DNA BINDING PROTEIN; PROTEIN BINDING; PROTEIN TDP-43;

CELL DEATH; CELL MEMBRANE; CELL SURVIVAL; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HELA CELL LINE; HUMAN; IMMUNOBLOTTING; METABOLISM; MUTATION; NICK END LABELING; PHYSIOLOGY;

ARSENITES; CELL DEATH; CELL MEMBRANE; CELL SURVIVAL; DNA-BINDING PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE; HELA CELLS; HUMANS; IMMUNOBLOTTING; IN SITU NICK-END LABELING; MUTATION; PROTEIN BINDING;

EID: 85005790350     PISSN: None     EISSN: 20515960     Source Type: Journal    
DOI: 10.1186/20515960149     Document Type: Article

References (41)

1. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, et al.: TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006, 351: 602-611. 10.1016/j.bbrc.2006.10.093
2. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, et al.: Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314: 130-133. 10.1126/science.1134108
3. Ou SH, Wu F, Harrich D, Garcia-Martinez LF, Gaynor RB: Cloning and characterization of a novel cellular protein, TDP-43, that binds to Human Immunodeficiency Virus Type 1 TAR DNA sequence motifs. J Virol 1995, 69: 3584-3596.
4. Buratti E, Brindisi A, Giombi M, Tisminetzky S, Ayala YM, et al.: TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J Biol Chem 2005, 280: 37572-37584. 10.1074/jbc.M505557200
5. Acharya KK, Govind CK, Shore AN, Stoler MH, Reddi PP: cis -Requirement for the maintenance of round spermatid-specific transcription. Dev Biol 2006, 295: 781-790. 10.1016/j.ydbio.2006.04.443
6. Wang HY, Wang IF, Bose J, Shen CK: Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics 2004, 83: 130-139. 10.1016/S0888-7543(03)00214-3
7. Mercado PA, Ayala YM, Romano M, Buratti E, Baralle FE: Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene. Nucleic Acids Res 2005, 33: 6000-6010. 10.1093/nar/gki897
8. Buratti E, Dork T, Zuccato E, Pagani F, Romano M, et al.: Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J 2001, 20: 1774-1784. 10.1093/emboj/20.7.1774
9. Strong MJ, Volkening K, Hammond R, Yang W, Strong W, et al.: TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol Cell Neurosci 2007, 35: 320-327. 10.1016/j.mcn.2007.03.007
10. Kim SH, Shanware NP, Bowler MJ, Tibbetts RS: Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA. J Biol Chem 2010, 285: 34097-34105. 10.1074/jbc.M110.154831
11. Rutherford NJ, Zhang YJ, Baker M, Gass JM, Finch NA, et al.: Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet 2008, 4: e1000193. 10.1371/journal.pgen.1000193
12. Davidson Y, Kelley T, Mackenzie IR, Pickering-Brown S, Du Plessis D, et al.: Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43. Acta Neuropathol 2007, 113: 521-533. 10.1007/s00401-006-0189-y
13. Johnson BS, McCaffery JM, Lindquist S, Gitler AD: A yeast TDP-43 proteinopathy model: exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc Natl Acad Sci U S A 2008, 105: 6439-6444. 10.1073/pnas.0802082105
14. Zhang YJ, Xu YF, Cook C, Gendron TF, Roettges P, Link CD, et al.: Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc Natl Acad Sci U S A 2009, 21: 7607-7612.
15. Zhang YJ, Xu YF, Dickey CA, Buratti E, Baralle F, et al.: Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. J Neurosci 2007, 27: 10530-10534. 10.1523/JNEUROSCI.3421-07.2007
16. Xu YF, Gendron TF, Zhang YJ, Lin WL, D'Alton S, et al.: Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J Neurosci 2010, 30: 10851-10859. 10.1523/JNEUROSCI.1630-10.2010
17. Shan X, Chiang PM, Price DL, Wong PC: Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice. Proc Natl Acad Sci U S A 2010, 107: 16325-16330. 10.1073/pnas.1003459107
18. Nonaka T, Arai T, Buratti E, Baralle FE, Akiyama H, et al.: Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells. FEBS Lett 2009, 583: 394-400. 10.1016/j.febslet.2008.12.031
19. Kedersha N, Anderson P: Mammalian stress granules and processing bodies. Methods Enzymol 2007, 431: 61-81.
20. Kedersha N, Anderson P: Stress granules: sites of mRNA triage that regulate mRNA stability and translatability. Biochem Soc Trans 2002, 30: 963-969.
21. McEwen E, Kedersha N, Song B, Scheuner D, Gilks N, et al.: Heme-regulated inhibitor kinase-mediated phosphorylation of eukaryotic translation initiation factor 2 inhibits translation, induces stress granule formation, and mediates survival upon arsenite exposure. J Biol Chem 2005, 280: 16925-16933. 10.1074/jbc.M412882200
22. McDonald KK, Aulas A, Destroismaisons L, Pickles S, Beleac E, et al.: TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1. Hum Mol Genet 2011, 20: 1400-1410. 10.1093/hmg/ddr021
23. Meyerowitz J, Parker SJ, Vella LJ, Ng D, Price KA, et al.: C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress. Mol Neurodegeneration 2011, 6: 57. 10.1186/1750-1326-6-57
24. Kip1 induces cell migration. Nat Med 1998, 4: 1449-1452. 10.1038/4042
25. Barber SC, Shaw PJ: Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic Biol Med 2010, 48: 629-641. 10.1016/j.freeradbiomed.2009.11.018
26. Parker SJ, Meyerowitz J, James JL, Liddell JR, Crouch PJ, et al.: Endogenous TDP-43 localized to stress granules can subsequently form protein aggregates. Neurochem Int 2012, 60: 415-424. 10.1016/j.neuint.2012.01.019
27. Guo A, Tapia L, Bamji SX, Cynader MS, Jia W: Progranulin deficiency leads to enhanced cell vulnerability and TDP-43 translocation in primary neuronal cultures. Brain Res 2010, 1366: 1-8.
28. Xu ZS: Does a loss of TDP-43 function cause neurodegeneration? Mol Neurodegeneration 2012, 7: 27. 10.1186/1750-1326-7-27
29. Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY, et al.: Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J Neurosci 2010, 30: 639-649. 10.1523/JNEUROSCI.4988-09.2010
30. Igaz LM, Kwong LK, Lee EB, Chen-Plotkin A, Swanson E, Unger T, Malunda J, et al.: Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. J Clin Invest 2011, 121: 726-738. 10.1172/JCI44867
31. Saudou F, Finkbeiner S, Devys D, Greenberg ME: Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 1998, 95: 55-66. 10.1016/S0092-8674(00)81782-1
32. Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S: Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 2004, 431: 805-810. 10.1038/nature02998
33. Subramaniam S, Sixt KM, Barrow R, Snyder SH: Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science 2009, 324: 1327-1330. 10.1126/science.1172871
34. Rao RV, Bredesen DE: Misfolded proteins, endoplasmic reticulum stress and neurodegeneration. Curr Opin Cell Biol 2004, 16: 653-662. 10.1016/j.ceb.2004.09.012
35. Kopito RR: Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 2000, 10: 524-530. 10.1016/S0962-8924(00)01852-3
36. Harding HP, Calfon M, Urano F, Novoa I, Ron D: Transcriptional and translational control in the mammalian unfolded protein response. Annu Rev Cell Dev Biol 2002, 18: 575-599. 10.1146/annurev.cellbio.18.011402.160624
37. Rutkowski DT, Kaufman RJ: A trip to the ER: coping with stress. Trends Cell Biol 2004, 14: 20-28. 10.1016/j.tcb.2003.11.001
38. Paschen W, Frandsen A: Endoplasmic reticulum dysfunction-a common denominator for cell injury in acute and degenerative diseases of the brain? J Neurochem 2001, 79: 719-725.
39. Ash PE, Zhang YJ, Roberts CM, Saldi T, Hutter H, et al.: Neurotoxic effects of TDP-43 overexpression in C. elegans. Hum Mol Genet 2010, 19: 3206-3218. 10.1093/hmg/ddq230
40. Hilpert K, Winkler DF, Hancock RE: Peptide arrays on cellulose support: SPOT synthesis, a time and cost efficient method for synthesis of large numbers of peptides in a parallel and addressable fashion. Nat Protoc 2007, 2: 1333-1349. 10.1038/nprot.2007.160
41. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF: In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 1999, 285: 1569-1572. 10.1126/science.285.5433.1569